Status:
UNKNOWN
Targeted Metabolic Profiling in Deep Vein Thrombosis
Lead Sponsor:
Imperial College London
Conditions:
Deep Vein Thrombosis
Eligibility:
All Genders
18+ years
Brief Summary
Deep venous thrombosis(DVT) is a blood clot, usually affecting the legs, causing pain, swelling, and redness. The clot damages the veins, which can result in chronic pain, swelling and ulceration. Thi...
Detailed Description
Deep venous thrombosis (DVT) is a blood clot, usually affecting the legs, causing pain, swelling, and redness. The clot damages the veins, which can result in chronic pain, swelling and ulceration. Th...
Eligibility Criteria
Inclusion
- \>18 years of age
- Willing/able to give written informed consent
- Patients with DVT and age and sex matched controls confirmed on duplex ultrasound
Exclusion
- Pregnancy (excluded based upon patient history, documented last menstrual period and urinary pregnancy test if patient unsure)
- Patients with blood borne disorders (HIV, Hepatitis B, C)
- Patients on systemic steroids and immunomodulating drugs
- Patients involved in a different venous research project or who have recently been involved with a venous research project
Key Trial Info
Start Date :
October 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04096755
Start Date
October 1 2019
End Date
May 1 2025
Last Update
August 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial College London, Academic Section of vascular Surgery, 4th floor East Wing, Charing Cross Hospital
London, United Kingdom, W6 8RF